190 related articles for article (PubMed ID: 32332463)
1. Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase.
Man WH; Wilting I; Souverein P; Meyboom R; Egberts T; Heerdink ER
J Clin Psychopharmacol; 2020; 40(3):283-286. PubMed ID: 32332463
[TBL] [Abstract][Full Text] [Related]
2. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-based subgroup analysis in VigiBase: effect on sensitivity in paediatric signal detection.
de Bie S; Verhamme KM; Straus SM; Stricker BH; Sturkenboom MC
Drug Saf; 2012 Apr; 35(4):335-46. PubMed ID: 22435344
[TBL] [Abstract][Full Text] [Related]
4. Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.
Mannesse CK; van Puijenbroek EP; Jansen PA; van Marum RJ; Souverein PC; Egberts TC
Drug Saf; 2010 Jul; 33(7):569-78. PubMed ID: 20553058
[TBL] [Abstract][Full Text] [Related]
5. Reported Adverse Drug Reactions in Children and Adolescents Treated with Antipsychotics.
Minjon L; van den Ban E; de Jong E; Souverein PC; Egberts TCG; Heerdink ER
J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):124-132. PubMed ID: 30676073
[TBL] [Abstract][Full Text] [Related]
6. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.
Pariente A; Gregoire F; Fourrier-Reglat A; Haramburu F; Moore N
Drug Saf; 2007; 30(10):891-8. PubMed ID: 17867726
[TBL] [Abstract][Full Text] [Related]
7. Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis.
Chen SY; Ravindran G; Zhang Q; Kisely S; Siskind D
CNS Drugs; 2019 Mar; 33(3):225-238. PubMed ID: 30758782
[TBL] [Abstract][Full Text] [Related]
8. Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBase.
Willemen MJ; Mantel-Teeuwisse AK; Straus SM; Meyboom RH; Egberts TC; Leufkens HG
Diabetes Care; 2011 Feb; 34(2):369-74. PubMed ID: 21270195
[TBL] [Abstract][Full Text] [Related]
9. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study.
Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G
Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848
[TBL] [Abstract][Full Text] [Related]
10. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.
Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M
Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028
[TBL] [Abstract][Full Text] [Related]
11. Amisulpride for clozapine induced sialorrhea.
Aggarwal A; Sharma DD
Psychopharmacol Bull; 2009; 42(4):69-71. PubMed ID: 20581795
[TBL] [Abstract][Full Text] [Related]
12. Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
Sagwa EL; Souverein PC; Ribeiro I; Leufkens HG; Mantel-Teeuwisse AK
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):1-8. PubMed ID: 27868278
[TBL] [Abstract][Full Text] [Related]
13. Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries.
De Las Cuevas C; Sanz EJ; Ruan CJ; de Leon J
Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):238-250. PubMed ID: 36513400
[TBL] [Abstract][Full Text] [Related]
14. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase.
De Las Cuevas C; Sanz EJ; Rohde C; de Leon J
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):65-78. PubMed ID: 35062840
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database.
de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL
Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063
[TBL] [Abstract][Full Text] [Related]
16. Seizure risk associated with neuroactive drugs: data from the WHO adverse drug reactions database.
Kumlien E; Lundberg PO
Seizure; 2010 Mar; 19(2):69-73. PubMed ID: 20036167
[TBL] [Abstract][Full Text] [Related]
17. Clozapine-induced sialorrhea: pathophysiology and management strategies.
Praharaj SK; Arora M; Gandotra S
Psychopharmacology (Berl); 2006 Apr; 185(3):265-73. PubMed ID: 16514524
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of clozapine-induced sialorrhea and its effect on quality of life.
Sanagustin D; Martin-Subero M; Hogg B; Fortea L; Gardoki I; Guinart D; Roldán M; Angelats M; Cerro L; Navas D; Jiménez JD; Ortiz L; Ros R; Polo X; Ventura Y; Contreras J; Moreno-Alcázar A; Pérez-Sola V; Amann BL; Valiente-Gómez A
Psychopharmacology (Berl); 2023 Jan; 240(1):203-211. PubMed ID: 36538098
[TBL] [Abstract][Full Text] [Related]
19. Genetic association between the DRD4 promoter polymorphism and clozapine-induced sialorrhea.
Rajagopal V; Sundaresan L; Rajkumar AP; Chittybabu C; Kuruvilla A; Srivastava A; Balasubramanian P; Jacob KS; Jacob M
Psychiatr Genet; 2014 Dec; 24(6):273-6. PubMed ID: 25304228
[TBL] [Abstract][Full Text] [Related]
20. Very Low Dose Amitriptyline for Clozapine-Associated Sialorrhea.
Sinha S; Simlai J; Praharaj SK
Curr Drug Saf; 2016; 11(3):262-3. PubMed ID: 27113954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
